The sensor lineup includes smart plugs, air quality monitors, and motion detectors, and automatically connects to Sidewalk ...
Lingo is Abbott’s over-the-counter continuous glucose monitor (CGM) for nondiabetic people. Withings users will also be able ...
The CES 2026 pre-show events have continued with Pepcom, as manufacturers vie for the attention of attendees. Here's the best ...
2025 is nearly over, and with just one day left of the year, there's no better time to start thinking about your goals for the new year. ZDNET's expert staff has tested numerous gadgets and gizmos ...
Irish Examiner on MSN
Composed Ulster come back to bite Connacht and secure bonus-point win
Connacht forced to settle for an all-too familiar losing bonus point in this one after again failing to build on a bright ...
What if you could transform your 3D printing workflow into a seamless, precision-driven process with just one tool? For enthusiasts and professionals alike, the journey from digital design to tangible ...
The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...
DexCom's growth rate has been accelerating for multiple quarters, and recently came in at around 22%. A rise in GLP-1 drugs has some investors concerned that DexCom's growth opportunities may be ...
Dexcom has issued a Class I recall for its G6 glucose sensor Android application due to a defect that causes the app to crash unexpectedly. As a result of the app terminating, users could miss ...
Dexcom has been hit by a major safety issue for an Android version of its G6 continuous glucose monitoring system app, leading the FDA to issue its most serious recall notice. A “software defect in ...
Oct 30 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback